Development of 95-gene classifier as a powerful predictor of recurrences in node-negative and ER-positive breast cancer patients

Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population

(2010) M. Ishitobi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Association Between the 21-Gene Recurrence Score Assay and Risk of Locoregional Recurrence in Node-Negative, Estrogen Receptor–Positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

(2010) Eleftherios P. Mamounas et al.   JOURNAL OF CLINICAL ONCOLOGY

The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

(2009) Christine Desmedt et al.   BMC Medical Genomics

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

(2009) Kathy S. Albain et al.   BREAST

Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

(2009) Koji Morimoto et al.   CANCER SCIENCE

Comparison of prognostic gene expression signatures for breast cancer

(2008) Benjamin Haibe-Kains et al.   BMC GENOMICS

Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

(2008) Sherene Loi et al.   BMC GENOMICS

Validation of 70-gene prognosis signature in node-negative breast cancer

(2008) J. M. Bueno-de-Mesquita et al.   BREAST CANCER RESEARCH AND TREATMENT

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

(2008) B. S. Wittner et al.   CLINICAL CANCER RESEARCH

Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial

(2008) Jo Anne Zujewski et al.   Future Oncology

Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials

(2008) Joseph A. Sparano et al.   JOURNAL OF CLINICAL ONCOLOGY